Bioler, Novegen's Phenoxodial trials have been halted - however that's not to say the drug is no use - I think it's being superceded by a the widely acting NV-128. An announcement came out yesterday worth reading... some further interpreation of the results. I think though Phenoxodial has been superceded by NV-128, which is an chemically similar (an anolog). NV-128 appears to inhibit cancer stem cells of many types of cancers... the info isn't clear or simple.
My guess is NV-128 could be a big winner, has superceded Phenoxodial, and could possibly have the same results for patients as cVac *might*. I see a small-medium risk here!!
NOTE: I am not a scientest, researcher, or otherwise! Gamble how you wish!
Bottom line though, Novogen are a company to watch. I'm holding them and increasing exporuse.
Unfortunately they aren't pennies ;)
I'm open to corrections!
a lot of stuff, page-32
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.015(4.92%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 32.5¢ | 30.0¢ | $1.168M | 3.702M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 148547 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 51809 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |